TL;DR
Get health and wellness essentials delivered free with Prime
- Fast, free delivery on millions of items
- Prime Video, Amazon Music and more included
- Member-only deals all year
A Sixty and Me article highlights research suggesting that high HDL, often called “good” cholesterol, does not always mean lower cardiovascular risk, particularly for some postmenopausal women. The report does not identify a new study or establish a universal target; it says HDL should be considered alongside other health factors and discussed with a clinician.
A Sixty and Me report says higher HDL cholesterol may not always signal lower cardiovascular risk, particularly for some postmenopausal women. The article challenges the familiar idea that more “good” cholesterol is invariably better, while emphasizing that HDL readings should be interpreted with a person’s broader health profile rather than used alone.
Cholesterol is a waxy substance the body uses to build cells and make hormones and vitamin D. The report says the body produces most of its cholesterol, largely in the liver, while a smaller share comes from food. Cholesterol circulating in the blood can contribute to plaque in artery walls; plaque may narrow arteries and is associated with risks such as heart attack and stroke.
HDL, or high-density lipoprotein, is commonly described as “good” cholesterol because it helps carry cholesterol away from the heart and arteries. LDL, or low-density lipoprotein, is commonly described as “bad” because elevated levels can contribute to plaque buildup. The report says this shorthand can obscure a more complicated picture: HDL concentration alone may not show how protective HDL is or capture a person’s overall cardiovascular risk.
The article points to possible differences after menopause and to genetic mutations that can produce high HDL without the expected protection. It also says both unusually high and low HDL levels have been associated with health risks in some research. However, it does not name the studies, explain their methods, or establish that a particular HDL number causes those outcomes. It presents 60–80 mg/dL as a suggested range, not a clinical target supported in the article by a named health authority or study.
Why HDL Alone Can Mislead
The message matters because a single cholesterol result can be easy to overinterpret. A high HDL figure may sound reassuring, but the report argues that it does not automatically cancel out other risks, including elevated LDL, diabetes, family history, or health changes associated with aging and menopause. Conversely, the article does not say that HDL is irrelevant; rather, it cautions against treating one measurement as a complete assessment.
For readers in their 60s, that distinction supports a more individualized discussion of cardiovascular risk. A clinician can interpret cholesterol results alongside other factors, medical history, and relevant examination or testing. The report mentions possible tests involving inflammation, deposits in arteries, blood-vessel function, and clotting, but does not specify which tests are appropriate for whom or demonstrate that every reader needs additional screening. Decisions about testing and treatment should be made with a qualified health professional.
Products Worth Considering
Fitbit Versa 2 Health and Fitness Smartwatch with Heart Rate, Alexa, Music, Sleep and Swim Tracking
Fitbit Inspire 3 Health and Fitness Tracker Bundle
LEVOIT Vital 200S-P Smart Air Purifier for Large Rooms
As an affiliate, we earn on qualifying purchases.
From Cholesterol Labels to Risk
The report reflects a long-running public explanation of cholesterol: HDL is “good,” LDL is “bad,” and higher HDL has often been described as beneficial. Those labels refer to different roles in cholesterol transport, but they are simplified descriptions. The supplied article says emerging evidence complicates the assumption that a higher HDL number always corresponds to stronger protection, including among some women after menopause.
The source is a consumer health article from Sixty and Me, not a detailed presentation of a clinical trial or formal guideline. It does not provide study titles, publication dates, participant numbers, or citations that would let readers assess the underlying findings. Its central point is therefore best understood as a caution about interpreting HDL in isolation, not as a replacement for established medical guidance or an instruction to aim for a particular number.
““Higher levels of HDL may not necessarily mean lower risk for cardiovascular disease in some postmenopausal older women.””
— Sixty and Me report
Evidence Behind the HDL Claims
The supplied report does not identify the research behind its claims about menopause, genetic mutations, very high HDL, or premature death. It does not explain whether the cited findings show correlation or causation, how “very high” levels were defined across studies, or how the findings apply to different groups. It also gives no source for the suggested 60–80 mg/dL range, so that figure should not be treated here as a universal target.
It remains unclear from this source how clinicians should use the cited findings in individual care or which additional tests may benefit particular patients. The article does not report a new guideline, a change in recommended treatment, or a specific clinical development. Readers should not change medication or pursue testing solely on the basis of the article; they can ask a clinician how their full risk profile should be assessed.
Discuss Results With Your Clinician
The practical next step described by the report is to review cholesterol results with a healthcare provider and discuss risks beyond HDL, including LDL, personal and family history, diabetes, activity, nutrition, and weight. A clinician can explain whether further evaluation is appropriate and how results fit into an individual prevention or treatment plan.
The source does not announce a forthcoming study or guideline update. Further clarity would require the underlying research citations and guidance from relevant health authorities. Until then, the report’s advice is limited but clear: treat HDL as one part of the health picture, not a standalone verdict on heart health.
Key Questions
Does a high HDL level guarantee protection from heart disease?
No. The Sixty and Me report says higher HDL does not always mean lower cardiovascular risk, particularly for some postmenopausal women. HDL is one measure and should be considered alongside other risk factors.
What HDL range does the report mention?
The report mentions 60–80 mg/dL as a suggested range, but it does not cite the research or a medical guideline supporting that target. It should not be taken as a universal goal; ask a clinician how to interpret your results.
Why does the article discuss menopause?
It says changes during and after menopause may affect how HDL relates to heart protection. The supplied source does not identify the studies or explain how those effects vary between individuals.
Should I request additional heart tests?
The report mentions tests that may look at inflammation, artery deposits, blood-vessel function, and clotting, but does not say who should receive them. Discuss your health history and testing options with a qualified healthcare professional.
Source: rss
